Previous close | 6.29 |
Open | 6.29 |
Bid | 11.60 |
Ask | 11.90 |
Strike | 15.00 |
Expiry date | 2025-01-17 |
Day's range | 6.29 - 6.29 |
Contract range | N/A |
Volume | |
Open interest | 20 |
Significant Revenue Growth Amidst Strategic Shifts and Clinical Developments
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2024 Earnings Call Transcript May 9, 2024 Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.75071 EPS, expectations were $0.24. AMLX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
Amylyx Pharmaceuticals (AMLX) delivered earnings and revenue surprises of -291.67% and 21.74%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?